Sodium iodide-i-131 Pregnancy and Breastfeeding Warnings
Sodium iodide-i-131 is also known as: Iodotope
Sodium iodide-i-131 Pregnancy Warnings
Sodium iodide-I-131 has been assigned to pregnancy category X by the FDA. Sodium iodide-I-131 is contraindicated in women who are or may become pregnant. Sodium iodide-I-131 readily crosses the placenta. The fetal thyroid is able to accumulate I-131 until after about 10 to 12 weeks of gestation. Therapeutic doses of sodium iodide-I-131 administered near the end of the first trimester (12 weeks or beyond) usually result in partial or complete abolition of the fetal thyroid. Patients treated with sodium iodide-I-131 should be advised to delay conception for at least six months after treatment. Animal reproduction studies have not been conducted with sodium iodide-I-131.
Sodium iodide-i-131 Breastfeeding Warnings
Sodium iodide-I-131 is concentrated in breast milk. Because exposure to radioactive iodine may result in damage to the nursing infants thyroid, including an increased risk of thyroid cancer, breast-feeding should be stopped until radioactivity is no longer present in breast milk.
See Also...
- Sodium Iodide I 131 use while Breastfeeding (in more detail)
- sodium iodide i 131 Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
